Total
0
Shares
AgraFlora Organics (CSE:AGRA) expects to enter edibles market in Q1
The Health Canada licensed 51,000 sq. foot manufacturing facility is located in Winnipeg, Manitoba. Source: Agraflora
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • AgraFlora Organics has completed the first phase of R&D trials at its automated edibles manufacturing facility
  • The Health Canada licensed 51,000 sq. foot manufacturing facility is located in Winnipeg, Manitoba
  • The company has created efficient processes for desired formulations and product varieties and expects to enter the edibles market in Q1 of 2021
  • The company said its edibles facility will utilize its current state of the art laboratory set-up to produce approximately 60,000 pieces per eight-hour shift
  • AgraFlora is up 40 per cent to C$0.035 per share

AgraFlora (AGRA) Organics has completed the first phase of R&D trials at its automated edibles manufacturing facility.

The Health Canada licensed 51,000 square-foot manufacturing facility is located in Winnipeg, Manitoba.

Prior to receiving a standard processing license from Health Canada, AgraFlora started cultivating long-term production relationships through Research and Development trials utilizing the company’s Health Canada R&D license.

The development phase of the R&D trials is now complete and the company has created efficient processes for desired formulations and product varieties and expects to enter the edibles market in the first quarter of 2021.

James Fletcher, Edibles and Infusions Corporation (AgraFlora's subsidiary) Co-Founder and Operational Manager, said supply contracts continue to move forward with the company's Licensed Producer relationships.

"We are confident that our gummies with consistent and flavourful variants will soon dominate the gummies category. Our family’s 97 years of confectionary experience provides us a solid culture of quality, craftmanship and efficiency to offer a variety of infused gummy products to multiple LP clients at a time,” he said.

Edibles and Infusions Corporation is a joint venture formed between AgraFlora and one of North America’s leading confectionary manufacturing families.

The company said its edibles facility will utilize its current state of the art laboratory set-up to produce approximately 60,000 pieces per eight-hour shift and can manage a variety of brands at once given the efficient nature of the automated production line.

The facility’s equipment and design allow Edibles and Infusions Corporation to easily pivot and provide specific dosing and custom gummies that meet regulatory requirements and customer specifications. These efficiencies also allow AgraFlora to produce saleable products at a lower cost.

AgraFlora is up 40 per cent to C$0.035 per share at 1:14pm EST.

More From The Market Herald
Nextleaf Solutions (CSE:OILS) awarded cannabis extraction patent in Israel

" Nextleaf Solutions (CSE:OILS) supplies rapid emulsion to BevCanna

Nextleaf Solutions Ltd. (OILS) is pleased to announce the initial order of Nextleaf’s Rapid concentrate to cannabis-infused beverage manufacturer, BevCanna Enterprises Inc.
CannMart (TSXV:N) and Wabi Sabi brands enter supply agreement

" Indiva (TSXV:NDVA) ships Wana Quick Gummies

Indiva Limited (NDVA) is taking a bite out of the cannabis edible market with the introduction of Wana Quick gummies.
PureK (TSXV:PKAN) acquires TRUBAR nutrition brand

" PureK (TSXV:PKAN) acquires TRUBAR nutrition brand

PureK Holdings (PKAN) has acquired the TRUBAR nutrition brand for its plant-based wellness portfolio.
Canntab (CSE: PILL) fulfills majority of its contract with MediPharm Labs

" Canntab (CSE: PILL) fulfills majority of its contract with MediPharm Labs

Canntab Therapeutics Limited (PILL) has completed its second delivery of two additional SKUs ordered by MediPharm Labs Corp.